Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...
University of Queensland researchers have received a $3.1 million grant for a trial which could revolutionize endometrial cancer treatment. Research Director Professor Andreas Obermair at UQ's ...
Role of ultrasound (US) and US-guided fine needle aspiration cytology (US-FNAC) prior to sentinel lymph node biopsy (SLNB) in 500 melanoma patients: Reduction of need for SNLB by high US-FNAC SN ...
Merkel cell carcinoma (MCC) is a complex, rare, aggressive disease that requires the expertise of multiple disciplines. As highlighted in the review by Banks et al, 1 we have seen some recent ...
Please provide your email address to receive an email when new articles are posted on . Patients receiving wide local excision or Mohs micrographic surgery showed similar survival outcomes (HR = 1.04) ...
Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...
Hosted on MSN
Could removing lymph nodes actually WEAKEN the immune system's power to attack cancer cells?
For years, it has been a mainstay of treatment to stop the spread of many cancers. But is the removal of lymph nodes – tiny, bean-shaped nodules that filter waste and bacteria – really the best way to ...
Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback